Another therapeutic target, which is probably more relevant for pediatric brain tumors with elevated myeloid cell infiltration, is cluster of differentiation 47 (CD47) on tumor cells that binds to signal-regulatory protein alpha (SIRPα) on myeloid cells and inhibits macrophage-induced phagocytosis [110]. This evidence concerns the gene SIRPA and brain neoplasm.